SPS
GILD icon

Susquehanna Portfolio Strategies’s Gilead Sciences GILD Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Sell
41,320
-36,940
-47% -$4.87M 0.08% 270
2026
Q1 		$10.9M Hold
78,260
– – 0.16% 164
2025
Q4 		$9.61M Buy
78,260
+35,221
+82% +$4.28M 0.15% 196
2025
Q3 		$4.78M Buy
43,039
+6,099
+17% +$693K 0.08% 321
2025
Q2 		$4.1M Buy
+36,940
New +$3.93M 0.09% 254
2024
Q1 		– Sell
-375,983
Closed -$30.5M – 856
2023
Q4 		$30.5M Buy
+375,983
New +$29.3M 0.54% 37

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna Portfolio Strategies's GILD Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Gilead Sciences (GILD) stake by 47% in Q2 2026, selling an estimated $4.87M and leaving 41,320 shares worth $5.22M. The position accounts for 0.08% of the portfolio, ranked #270.

Susquehanna Portfolio Strategies first reported a position in GILD in Q4 2023 and has held it in 6 quarters since. The position peaked at $30.5M in Q4 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Susquehanna Portfolio Strategies held 41,320 shares of Gilead Sciences worth $5.22M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 36,940 Gilead Sciences shares in Q2 2026, an estimated $4.87M.
  • Gilead Sciences made up 0.08% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #270 holding.
  • Susquehanna Portfolio Strategies first reported a position in Gilead Sciences in Q4 2023 and has held it in 6 quarters since.
  • Susquehanna Portfolio Strategies's Gilead Sciences position peaked at $30.5M in Q4 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.